Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $44.9 million.

  • Vanda Pharmaceuticals' Cash from Investing Activities rose 102361.63% to $44.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $94.9 million, marking a year-over-year increase of 64423.41%. This contributed to the annual value of $94.9 million for FY2025, which is 64423.41% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Cash from Investing Activities of $44.9 million as of Q4 2025, which was up 102361.63% from $21.4 million recorded in Q3 2025.
  • Vanda Pharmaceuticals' 5-year Cash from Investing Activities high stood at $187.3 million for Q1 2023, and its period low was -$190.9 million during Q2 2023.
  • Over the past 5 years, Vanda Pharmaceuticals' median Cash from Investing Activities value was -$7.3 million (recorded in 2021), while the average stood at $1.9 million.
  • In the last 5 years, Vanda Pharmaceuticals' Cash from Investing Activities tumbled by 135113.47% in 2021 and then soared by 1520422.54% in 2022.
  • Vanda Pharmaceuticals' Cash from Investing Activities (Quarter) stood at -$26.0 million in 2021, then surged by 390.13% to $75.4 million in 2022, then plummeted by 158.05% to -$43.8 million in 2023, then soared by 109.12% to $4.0 million in 2024, then skyrocketed by 1023.62% to $44.9 million in 2025.
  • Its Cash from Investing Activities was $44.9 million in Q4 2025, compared to $21.4 million in Q3 2025 and -$15.3 million in Q2 2025.